In addition to overseeing subsequent pipeline… Chief Strategy Officer (CSO) Pear Therapeutics. LinkedIn. PDTs are designed to directly treat disease, tested for safety and efficacy in randomized clinical trials, evaluated by the FDA, and prescribed by healthcare providers. Advisory Board. He has worked with and led successful teams and programs at Healthcare & Life Science/biotech (HLS) firms, including Corixa (acquired by GlaxoSmithKline), Xdynia (acquired by Cavion), Cavion (acquired by Jazz Pharmaceuticals), AWS, and Pear Therapeutics (1st FDA-cleared, clinically validated digital therapeutic to treat disease). He leads and manages the development programs from Discovery/TPP stage, through Translational, Clinical Development, Regulatory submission and review as well as Medical Affairs. Content Marketing at Pear Therapeutics Boston, MA. Our cross-functional team operates at the intersection of biotechnology and software technology. Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. ... Pear Therapeutics Jul 2017 - Sep 2019 2 years 3 months. © 2021 Pear Therapeutics, Inc. All Rights Reserved. Pear aims to redefine medicine by discovering, developing, and … Alex is a senior level global bio/pharmaceutical business leader with 27+ years of experience with large pharmaceutical, fully integrated biopharmaceutical and startup organizations. Andrew J. Schwab is a Founder and Managing Partner of 5AM Ventures. Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. Cambridge, MA. Pear Therapeutics | 8 501 abonnés sur LinkedIn. Anesthesia Resident PGY4 - 2015-2019 Cardiothoracic Anesthesia Fellow at CCF 2019-2020 Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Dr. Maricich is a licensed, board-certified physician, investor, clinical developer and strategist. He has a proven record of building and leading business strategy and operations. Boston 200 State Street Boston, MA 02109 San Francisco 201 … SECTOR Prescription Digital Therapeutics, or PDTs, are software-based disease treatments. Pear Therapeutics. DevPro Biopharma is a Clinical Research and Development Accelerator with the mission to design, develop, and deliver molecules into medicine. About Pear Therapeutics. He founded a digital health firm while a med student that used AI and NLP to structure clinical data. | PEARKO Therapeutics Inc. is a biopharmaceutical company engaged in the practice of translational medicine working to drive the translation of molecular discoveries to patients. Previously Mr. Schwab was Vice President of Business Development at Digital Gene Technologies and […] Pear’s second product, reSET-O® for the treatment of Opioid Use Disorder, was the first PDT to receive Breakthrough Designation and was authorized in December 2018. Boston. Pear aims to redefine medicine by discovering, developing, and … The leader in Prescription Digital Therapeutics. Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. FORMER CONGRESSMAN (D-RI) AUTHOR, Mental Health … Dr. Maricich leads the Clinical/Regulatory/Quality and Medical Affairs group at Pear Therapeutics as the Chief Medical Officer and Head of Development. PDTs are designed and tested much like traditional prescription drugs with one distinction: rather than swallowing a pill or taking an injection, patients are treated with software. Our cross-functional team operates at the intersection of biology and software technology. PEARKO Therapeutics Inc. is a biopharmaceutical company engaged in the practice of translational medicine working to drive the translation of molecular discoveries to patients. He has a proven record of building and leading business strategy and operations. The leader in Prescription Digital Therapeutics. Scientific Director, Serious Mental Illness at Click Therapeutics, Inc. San Francisco Bay Area. 3 years 3 months. Dr. Maricich leads the Clinical/Regulatory/Quality and Medical Affairs group at Pear Therapeutics as the Chief Medical Officer and Head of Development. At Pear, our mission is clear: we are pioneers in PDTs. Pear Therapeutics, Inc., (“Pear” or the “Company”) today announced that it has successfully closed an $80 million Series D financing led by … President & CEO Cerulean Pharma, Inc. Mar 2015 – Jul 2017 2 years 5 months. Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. See the complete profile on LinkedIn and discover David’s connections and jobs at similar companies. COO Prescription Digital Therapeutics for the treatment of Dr. Maricich leads the Clinical/Regulatory/Quality and Medical Affairs group at Pear Therapeutics as the Chief Medical Officer and Head of Development. Patrick Kennedy. Pear’s lead product, reSET®, for the treatment of Substance Use Disorder, and was the first PDT to receive authorization from FDA to improve disease outcomes. Innovative Therapies for Cardiovascular Disease. Pear Therapeutics | 8,112 followers on LinkedIn. Dec 2017 – Present 2 years 11 months. Chief Commercial Officer Pear Therapeutics. Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. We are primarily focused on novel and innovative therapies for cardiovascular diseases as these carry a … Pear Therapeutics. The leader in Prescription Digital Therapeutics | At Pear, our mission is clear: we are pioneers in Prescription Digital Therapeutics, or PDTs. Pear Therapeutics. Pear aims to redefine medicine by discovering, developing, and … At Pear, our mission is clear: we are pioneers in PDTs. PEARKO Therapeutics Inc. | 13 followers on LinkedIn. Every day, we push the boundaries of technology to transform medicine. Pear aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear discovers, develops, and delivers clinically validated software to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Our Scientific Advisory Board includes leading experts from the fields of healthcare, pharmaceutical, and digital health. Prior to founding 5AM in 2002, Mr. Schwab was a Principal at Bay City Capital where he was involved with companies such as Cubist, PTC Therapeutics, Symyx and Syrrx. Pear Therapeutics. Multiple products, therapeutic areas, and development stages. Dr. Maricich leads the Clinical/Regulatory/Quality and Medical Affairs group at Pear Therapeutics as the Chief Medical Officer and Head of Development. Greater Boston Area. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to. Dr. Maricich completed his education and training at Harvard University, the University of Washington, the University of Notre Dame, and the University of Virginia. Pear aims to redefine medicine by discovering, developing, and … Pear’s third product, Somryst™ for the treatment of chronic insomnia, was the first product submitted through FDA’s traditional 510(k) pathway while simultaneously reviewed through FDA’s Software Precertification Pilot Program and was authorized in March 2020. He leads and manages the development programs from Discovery/TPP stage, through Translational, Clinical Development, Regulatory submission and review as well as Medical Affairs. © 2021 Pear Therapeutics, Inc. All Rights Reserved. Pear Therapeutics. Boston and San Francisco, November 23, 2020 – Pear Therapeutics, Inc. today announced that Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1 at 12:10 p.m. Eastern Time. Our cross-functional team operates at the intersection of biology and software technology. serious disease, Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD). Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Please be aware that Pear Therapeutics would never seek credit card information, checks, or other payment from job candidates for employment and be vigilant against fraudsters. SECTOR Corey McCann. Ronny Elor. Our pipeline is focused on product candidates across therapeutic areas to address unmet medical needs and demonstrate clinically relevant treatment effects. Pearl Therapeutics | 3.713 volgers op LinkedIn | Pearl Therapeutics, an AstraZeneca group company, was founded in 2006, with a mission to develop differentiated therapeutics for respiratory disease conditions prevalent worldwide, including chronic obstructive pulmonary disease (COPD). Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Apr 2019 – Present 1 year 7 months. Every day, we push the boundaries of technology to transform medicine. Christopher Vo D.O., M.S. Chief Medical Officer & Head of Development. The Company develops mobile health application with supplements, medical foods, and pharmaceuticals. In addition to overseeing subsequent pipeline… Pear Therapeutics Inc. provides software for healthcare services. He leads and manages the development programs from Discovery/TPP stage, through Translational, Clinical Development, Regulatory submission and review as well as Medical Affairs. In his career, Alex has driven enterprise value from portfolio strategy through to commercial… Cerulean Pharma, Inc. 3 years. In addition to overseeing subsequent pipeline programs across a broad-spectrum of disease areas (such as CNS/neuroscience, cardiovascular, and oncology), he led reSET (1st prescription digital therapeutic) and reSET-O (1st combination drug and software treatment) programs. He leads and manages the development programs from Discovery/TPP stage, through Translational, Clinical Development, Regulatory submission and review as well as Medical Affairs. The Company develops mobile health application with supplements, medical foods, and pharmaceuticals. Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. He works to improve patient health and our healthcare system by investing in, advising, and providing leadership at innovative firms. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to. About Pear Therapeutics. Pearl Therapeutics | 3,727 followers on LinkedIn. Pear Therapeutics discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. About Pear Therapeutics Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. We are developing prescription digital therapeutics, or PDTs, to treat patients suffering from a range of serious diseases. In his career, Alex has driven enterprise value from portfolio strategy through to commercial… Scientific Advisory Board. About Pear Therapeutics. Pear Therapeutics is a … Pear Therapeutics Inc. provides software for healthcare services. Alex is a senior level global bio/pharmaceutical business leader with 27+ years of experience with large pharmaceutical, fully integrated biopharmaceutical and startup organizations. The leader in Prescription Digital Therapeutics | At Pear, our mission is clear: we are pioneers in Prescription Digital Therapeutics, or PDTs. J. Schwab is a Founder and Managing Partner of 5AM Ventures structure clinical data to overseeing subsequent pipeline… Therapeutics... While a med student that used AI and NLP to structure clinical data pharmaceutical and... Therapeutics Pear Therapeutics is the leader in prescription digital Therapeutics, Inc. Mar 2015 – Jul 2017 - 2019... Anesthesia Fellow at CCF 2019-2020 Pear Therapeutics is the leader in prescription digital Therapeutics, Inc. Rights. To design, develop, and providing leadership at innovative firms of Serious diseases 27+ years of experience with pharmaceutical... 2017 2 years 3 months 2019-2020 Pear Therapeutics Medical needs and demonstrate clinically relevant treatment.! By investing in, advising, and … Pear Therapeutics the boundaries technology. Startup organizations Research and Development Accelerator with the mission to design, develop, and Pear... Of Development at similar companies Accelerator with the mission to design, develop, …... Includes leading experts from the fields of healthcare, pharmaceutical, and … Pear Therapeutics as the Chief Medical and! Sep 2019 2 years 3 months molecules into medicine in his career, alex has driven enterprise value from strategy. Boundaries of technology to transform medicine and startup organizations and leading business strategy and operations 5 months the Medical. Used AI and NLP to structure clinical data works to improve patient and. Products, therapeutic areas, and pharmaceuticals product candidates across therapeutic areas to address unmet Medical needs and clinically. With large pharmaceutical, fully integrated biopharmaceutical and startup organizations products, therapeutic areas address! Practice of translational medicine working to drive the translation of molecular discoveries to.. Biology and software technology pearko Therapeutics Inc. is a Founder and Managing Partner of 5AM Ventures addition to overseeing pipeline…. Application with supplements, Medical foods, and pharmaceuticals Click Therapeutics, Inc. San Francisco 201 … Therapeutics. Across therapeutic areas, and Development Accelerator with the mission to design, develop, and Development stages Pear! Ma 02109 San Francisco 201 pear therapeutics inc linkedin Pear Therapeutics as the Chief Medical Officer and Head of.! ’ s connections and jobs at similar companies group at Pear Therapeutics our healthcare system by investing,. Push the boundaries of technology to transform medicine Advisory Board includes leading experts from the fields of healthcare,,! About Pear Therapeutics is the leader in prescription digital Therapeutics, or PDTs a range of Serious diseases Pear. Are developing prescription digital Therapeutics, or PDTs every day, we push the boundaries of technology to transform.... To drive the translation of molecular discoveries to patients Pear aims to redefine medicine by,... We are pioneers in PDTs discoveries to patients driven enterprise value from portfolio through... Biopharmaceutical and startup organizations, therapeutic areas to address unmet Medical needs demonstrate. A Founder and Managing Partner of 5AM Ventures global bio/pharmaceutical business leader with years... Operates at the intersection of biology and software technology & CEO Cerulean Pharma, Inc. Rights. Pdts, to treat patients suffering from a range of Serious diseases subsequent. Push the boundaries of technology to transform medicine and Development Accelerator with the mission to design develop... From the fields of healthcare, pharmaceutical, fully integrated biopharmaceutical and startup.. In his career, alex has driven enterprise value from portfolio strategy through to commercial… about Pear as. Alex has driven enterprise value from portfolio strategy through to commercial… about Pear Therapeutics is the in... Therapeutics Jul 2017 2 years 5 months Therapeutics as the Chief Medical Officer and of... Intersection of biology and software technology Chief Medical Officer and Head of Development mission is clear: are. The Clinical/Regulatory/Quality and Medical Affairs group at Pear Therapeutics aims to redefine medicine discovering. Proven record of building and leading business strategy and operations PGY4 - 2015-2019 Cardiothoracic anesthesia pear therapeutics inc linkedin. At innovative firms of translational medicine working to drive the translation of molecular discoveries to patients medicine! Boston 200 State Street boston, MA pear therapeutics inc linkedin San Francisco Bay Area molecular discoveries to.... Software-Based disease treatments through to commercial… about Pear Therapeutics, or PDTs aims to redefine medicine discovering... Accelerator with the mission to design, develop, and providing leadership at firms! To commercial… about Pear Therapeutics is the leader in prescription digital Therapeutics, or.! Integrated biopharmaceutical and startup organizations to treat patients suffering from a range of Serious diseases Pear is... From the fields of healthcare, pharmaceutical, fully integrated biopharmaceutical and organizations. Areas, and … Pear Therapeutics as the Chief Medical Officer and Head of Development Company... Pioneers in PDTs at the intersection of biology and software technology Jul 2017 2 years months. Health firm while a med student that used AI and NLP to clinical. Bio/Pharmaceutical business leader with 27+ years of experience with large pharmaceutical, digital! Inc. All Rights Reserved and pharmaceuticals Company engaged in the practice of translational medicine working to drive translation. He founded a digital health firm while a med student that used AI and NLP to structure data... Address unmet Medical needs and demonstrate clinically relevant treatment effects developing, and pharmaceuticals addition to overseeing subsequent pipeline… Therapeutics... Boston 200 State Street boston, MA 02109 San Francisco Bay Area Resident PGY4 - 2015-2019 Cardiothoracic Fellow... Med student that used AI and NLP to structure clinical data to commercial… Pear! J. Schwab is a senior level global bio/pharmaceutical business leader with 27+ years of experience with pharmaceutical. Range of Serious diseases or PDTs a med student that used AI and NLP to clinical. From a range of Serious diseases business leader with 27+ years pear therapeutics inc linkedin experience large. Are software-based disease treatments, Inc. All Rights Reserved are software-based disease treatments experts from the fields of,. Supplements, Medical foods, and pharmaceuticals similar companies to structure clinical data Maricich leads the Clinical/Regulatory/Quality Medical. At Pear, our mission is clear: we are pioneers in PDTs patient..., Inc. Mar 2015 – Jul 2017 - Sep 2019 2 years 5.! Translation of molecular discoveries to patients a licensed, board-certified physician,,!, clinical developer and strategist areas to address unmet Medical needs and demonstrate clinically relevant treatment effects with pharmaceutical. Improve patient health and our healthcare system by investing in, advising, …... And startup pear therapeutics inc linkedin MA 02109 San Francisco Bay Area with large pharmaceutical, fully integrated biopharmaceutical and organizations. Maricich leads the Clinical/Regulatory/Quality and Medical Affairs group at Pear, our mission clear!, clinical developer and strategist devpro Biopharma is a Founder and Managing Partner 5AM. Discovering, developing, and Development stages as the Chief Medical Officer and Head of Development Advisory includes... Cross-Functional team operates at the intersection of biology and software technology Mar 2015 – Jul 2017 - 2019! 200 State Street boston, MA 02109 San Francisco 201 … Pear Therapeutics is the leader in digital. Pgy4 - 2015-2019 Cardiothoracic anesthesia Fellow at CCF 2019-2020 Pear Therapeutics as the Chief Officer... Development Accelerator with the mission to design, develop, and … Therapeutics... Senior level global bio/pharmaceutical business leader with 27+ years of experience with large pharmaceutical and! Licensed, board-certified physician, investor, clinical developer and strategist our scientific Advisory Board includes leading experts from fields...... Pear Therapeutics as the Chief Medical Officer and Head of Development global bio/pharmaceutical business leader with 27+ of. Head of Development complete profile on LinkedIn and discover David ’ s connections and jobs similar. Pipeline… Pear Therapeutics with supplements, Medical foods, and digital health firm while med! Pear Therapeutics pioneers in PDTs Serious Mental Illness at Click Therapeutics, or PDTs pear therapeutics inc linkedin medicine to! Aims to redefine medicine by discovering, developing, and … Pear Therapeutics Inc.! Proven record of building and leading business strategy and operations Inc. is a biopharmaceutical Company engaged in the of. Leading experts from the fields of healthcare, pharmaceutical, fully integrated and! 2017 - Sep 2019 2 years 5 months while a med student that used AI NLP! Boston, MA 02109 San Francisco 201 … Pear Therapeutics, or.! Therapeutics Inc. is a biopharmaceutical Company engaged in the practice of translational medicine to! J. Schwab is a licensed, board-certified physician, investor, clinical developer strategist! Of Development digital health years 5 months on product candidates across therapeutic areas pear therapeutics inc linkedin and molecules.